Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

Fig. 2

(a) Kaplan-Meier curve of overall survival for 30 cancer patients with active Mycobacterium tuberculosis who received concurrent chemotherapy between January 1, 2006 and February 29, 2016. The median OS in all patients was 10.5 (8.7–36.7; 95.0% confidence interval) months (b) Kaplan-Meier curves of overall survival according to cancer type. Lung Cancer patients are represented by the thick solid line, Colorectal Cancer patients are represented by the thin solid line, and patients with Other malignancies, are represented by the dashed line. The median OS according to the type of malignancy were 8.7 (4.7–10.0), 36.7 (minimum 2.2), and 14.4 (minimum 9.6) months for Lung Cancer, Colorectal Cancer, and Other malignancies, respectively

Back to article page